0001140361-14-023925.txt : 20140623 0001140361-14-023925.hdr.sgml : 20140623 20140602105532 ACCESSION NUMBER: 0001140361-14-023925 CONFORMED SUBMISSION TYPE: SC 13D PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20140602 DATE AS OF CHANGE: 20140602 GROUP MEMBERS: BRIAN PESSIN GROUP MEMBERS: SANDRA F. PESSIN SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: CAS MEDICAL SYSTEMS INC CENTRAL INDEX KEY: 0000764579 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 061123096 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D SEC ACT: 1934 Act SEC FILE NUMBER: 005-41615 FILM NUMBER: 14882725 BUSINESS ADDRESS: STREET 1: 44 EAST INDUSTRIAL ROAD CITY: BRANFORD STATE: CT ZIP: 06405 BUSINESS PHONE: 2034886056 MAIL ADDRESS: STREET 1: 44 EAST INDUSTRIAL ROAD CITY: BRANFORD STATE: CT ZIP: 06405 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: PESSIN NORMAN H CENTRAL INDEX KEY: 0000923666 FILING VALUES: FORM TYPE: SC 13D MAIL ADDRESS: STREET 1: C/O LEVY, HARKINS & CO., INC. STREET 2: 366 MADISON AVENUE, 14TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10017 SC 13D 1 formsc13d.htm NORMAN PESSIN SC 13D 5-30-2014 (CAS MEDICAL SYSTEMS)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13D

Under the Securities Exchange Act of 1934
(Amendment No.  )*

CAS Medical Systems, Inc.
 (Name of Issuer)

Common Stock, $.004 par value
 (Title of Class of Securities)

124769 20 9
Cusip Number

Norman H. Pessin
Brian Pessin
366 Madison Avenue, 14th Floor
New York, NY  10017
212-661-2670
   
(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

May 30, 2014
 (Date of Event which Requires Filing
of this Statement)

If the filing person has previously filed a statement of Schedule 13G to report the acquisition which is the subject of the Schedule 13D, and is filing this schedule because of ss. 240.13d-1(e), ss. 240.13d-1(f) or ss. 240.13d-1(g), check the following box o.

Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See ss.240.13d-7(b) for other parties to whom copies are to be sent.

*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
PAGE 2
CUSIP No. 124769 20 9
Schedule 13D
         
1
NAME OF REPORTING PERSON
 
 
 
Norman H. Pessin
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
 
(a)  þ  (b) o
 
3
SEC USE ONLY
 
 
4
SOURCE OF FUNDS
 
PF
 
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) o
      
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
United States
      
NUMBER OF SHARES
7
SOLE VOTING POWER
 
BENEFICIALLY
 
180,377
OWNED BY EACH
8
SHARED VOTING POWER
 
REPORTING
 
 
PERSON WITH
9
SOLE DISPOSITIVE POWER
 
 
 
180,377
 
10
SHARED DISPOSITIVE POWER
     
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
180,377
    
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* o
    
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
1) 0.9%
     
14
TYPE OF REPORTING PERSON*
 
IN
PAGE 3
CUSIP No. 124769 20 9
Schedule 13D
        
1
NAME OF REPORTING PERSON
 
 
 
Sandra F. Pessin
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
 
(a)  þ  (b) o
 
3
SEC USE ONLY
 
 
4
SOURCE OF FUNDS
 
PF
 
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) o
      
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
United States
      
NUMBER OF SHARES
7
SOLE VOTING POWER
 
BENEFICIALLY
 
625,000
OWNED BY EACH
8
SHARED VOTING POWER
 
REPORTING
 
 
PERSON WITH
9
SOLE DISPOSITIVE POWER
 
 
 
625,000
 
10
SHARED DISPOSITIVE POWER
     
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
625,000
      
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* o
      
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
3.2%
      
14
TYPE OF REPORTING PERSON*
 
IN

PAGE 4
CUSIP No. 124769 20 9 
Schedule 13D
     
1
NAME OF REPORTING PERSON
 
 
 
Brian Pessin
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
 
(a)  þ  (b) o
 
3
SEC USE ONLY
 
 
4
SOURCE OF FUNDS
 
PF
 
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) o
      
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
United States
      
NUMBER OF SHARES
7
SOLE VOTING POWER
 
BENEFICIALLY
 
182,346
OWNED BY EACH
8
SHARED VOTING POWER
 
REPORTING
 
 
PERSON WITH
9
SOLE DISPOSITIVE POWER
 
 
 
 
 
182,346
 
10
SHARED DISPOSITIVE POWER
     
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
182,346
    
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* o
    
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
0.9%
     
14
TYPE OF REPORTING PERSON*
 
IN
 
PAGE 5
CUSIP No.  124769 20 9
Schedule 13D

Item 1.
Security and Issuer
 
This Schedule 13D relates to the common stock, $.004 par value (the "Common Stock" or the “Shares”),of CAS Medical Systems, Inc. (the "Issuer"),whose principal executive offices are located at 44 East Industrial Road, Branford, CT 06405.

Item 2.
Identity and Background

This Schedule 13D is being filed by and for Norman H. Pessin, Sandra F. Pessin, and Brian Pessin (each a “Reporting Person”).  Certain information with respect to each Reporting Person is set forth below:

Name and Address:
1) Norman H. Pessin
 
366 Madison Avenue, 14th Floor
 
New York, NY  10017
 
 
 
2) Sandra F. Pessin
 
366 Madison Avenue, 14th Floor
 
New York, NY  10017
 
 
 
3) Brian Pessin
 
310 East 75th Street, Apt. 2A
 
New York, NY  10021
 
 
Principal Occupation:
1) Investor
 
2) Housewife
 
3) Investor
 
 
Criminal Convictions:
1) None
 
2) None
 
3) None
 
 
Civil Proceedings:
1) None
 
2) None
 
3) None
 
 
Citizenship:
1) United States
 
2) United States
 
3) United States

Item 3.
Source and Amount of Funds or Other Consideration

The aggregate purchase price of the 180,377 shares of Common Stock owned by Norman H. Pessin is approximately $275,845, including brokerage commissions.  The shares of Common Stock owned by Norman H. Pessin were acquired with personal funds.  The aggregate purchase price of the 625,000 shares of Common Stock owned by Sandra F. Pessin is approximately $841,250, including brokerage commissions.  The shares of Common Stock owned by Sandra F. Pessin were acquired with personal funds.  The aggregate purchase price of the 182,346 shares of Common Stock owned by Brian Pessin is approximately $309,373, including brokerage commissions.  The shares of Common Stock owned by Brian Pessin were acquired with personal funds.
PAGE 6
CUSIP No. 124769 20 9
Schedule 13D
 
Item 4.
Purpose of Transaction

The Reporting Persons originally purchased the Shares based on the belief that the Shares, when purchased, were undervalued and represented an attractive investment opportunity.  Depending upon overall market conditions, other investment opportunities available to the Reporting Persons, and the availability of Shares at prices that would make the purchase or sale of Shares desirable, the Reporting Persons may endeavor to increase or decrease their position in the Issuer through, among other things, the purchase or sale of Shares on the open market or in private transactions or otherwise, on such terms and at such times as the Reporting Persons may deem advisable.

The Reporting Persons intend to review their investment in the Issuer on a continuing basis.  Depending on various factors including, without limitation, the Issuer’s financial position and investment strategy, the price levels of the Shares, conditions in the securities markets and general economic and industry conditions, the Reporting Persons may in the future take such actions with respect to their investment in the Issuer as they deem appropriate including, without limitation, communications with management and the Board of Directors of the Issuer, engaging in discussions with third parties about the Issuer, making proposals to the Issuer concerning changes to the capitalization or operations of the Issuer, purchasing additional Shares, selling some or all of their Shares, engaging in short selling of or any hedging or similar transaction with respect to the Shares, or changing their intention with respect to any and all matters referred to in Item 4.

Item 5.
Interest in Securities of the Issuer

Norman H. Pessin owns 180,377 shares of Common Stock of the Issuer, constituting 0.9% of the outstanding shares thereof.  Sandra F. Pessin owns 625,000 shares of Common Stock of the Issuer, constituting 3.2% of the outstanding shares thereof.  Brian Pessin owns 182,346 shares of Common Stock of the Issuer, constituting 0.9% of the outstanding shares thereof.

Norman Pessin has sole voting and dispositive power with respect to the shares of Common Stock he owns directly.  Mrs. Pessin has sole voting and dispositive power with respect to the shares of Common Stock she owns directly.  Brian Pessin  has sole voting and dispositive power with respect to the shares of Common Stock she owns directly.

Schedule A attached hereto lists all transactions in securities of the Issuer during the past sixty days by the Reporting Persons.  All of such transactions were effected in the open market.

No person other than the Reporting Persons is known to have the right to receive, or the power to direct the receipt of dividends from, or proceeds from the sale of, the shares of Common Stock.

PAGE 7
CUSIP No. 124769 20 9
Schedule 13D
 
Item 6.
Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer

None.

Item 7.
Material to Be Filed as Exhibits

None.

Signatures

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
 
 
  /s/ Norman H. Pessin 
 
 
Norman H. Pessin
 
 
 
 
 
   /s/ Sandra F. Pessin
 
 
Sandra F. Pessin
 
 
 
 
 
 /s/ Brian Pessin
 
 
Brian Pessin
 

May 30, 2014

Schedule A

Transactions in the Securities of the Issuer During the Past 60 Days

Shares of Common
Stock Purchased
Price Per
Share ($)
Date of
Purchase
 
 
 
 
Norman H. Pessin
 
 
 
 
20,307
2.10
5/29/14